[Expression and immunogenicity evaluation of ectodomain and subdomains of Plasmodium berghei apical membrane antigen 1]
- PMID: 17639690
[Expression and immunogenicity evaluation of ectodomain and subdomains of Plasmodium berghei apical membrane antigen 1]
Abstract
Objective: To express and evaluate the immunogenicity of ectodomain and its subdomains of Plasmodium berghei apical membrane antigen I (PbAMA-1).
Methods: Sequence of PbAMA-I gene was isolated from the genome of P. berghei, and was redesigned and divided into three overlapped fragments according to its subdomain structure. The codon-optimized DNA fragments of PbAMA-1 were synthesized and inserted into vector pET32a for expression in E. coli and the recombinant proteins were purified by Ni-NTA column, followed by refolding in vitro. Mice and rabbits were immunized with the recombinant proteins formulated with Freund adjuvant. Titer of the specific antibodies was detected by ELISA and IFA. The immunized mice were challenged by P. berghei to evaluate protective efficacy in vivo.
Results: The sequence of the PbAMA-1 gene was shown to be identical to that published before. PbAMA-1 sequence was redesigned via codon optimization and synthesized. Both ectodomain and its subdomains of PbAMA-1 were successfully expressed in E. coli after induction. The proteins were isolated with the purity of more than 90% after Ni column purification and refolding in vitro. Immunization of mice with the recombinant proteins induced high level of specific antibodies. The antibody titer to ectodomain E after the 3rd immunization showed a strong immunogenicity at (34.4+/-0.15) x 10(-4). The antibodies interacted with the parasites by indirect fluorescence. The immunized mice were partially protected from the challenge of P. berghei.
Conclusion: The recombinant PbAMA-1 is highly immunogenic and induces protective immunity against the challenge of P. berghei.
Similar articles
-
[Construction and expression of Plasmodium berghei chimeric protein in Pichia pastoris and its immunogenicity in mice].Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2008 Oct 30;26(5):327-31. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2008. PMID: 19157293 Chinese.
-
Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.Vaccine. 2008 Aug 18;26(35):4526-35. doi: 10.1016/j.vaccine.2008.06.031. Epub 2008 Jun 30. Vaccine. 2008. PMID: 18590786
-
[Protective antibody response to recombinant fragments of Plasmodium falciparum apical membrane antigen 1].Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2003;21(2):80-3. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2003. PMID: 12884614 Chinese.
-
Plasmodium berghei HAP2 induces strong malaria transmission-blocking immunity in vivo and in vitro.Vaccine. 2009 Aug 20;27(38):5187-94. doi: 10.1016/j.vaccine.2009.06.069. Epub 2009 Jul 9. Vaccine. 2009. PMID: 19596419 Review.
-
Apical membrane antigen 1: a malaria vaccine candidate in review.Trends Parasitol. 2008 Feb;24(2):74-84. doi: 10.1016/j.pt.2007.12.002. Epub 2008 Jan 15. Trends Parasitol. 2008. PMID: 18226584 Review.
Cited by
-
The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment.Sci Rep. 2013;3:1706. doi: 10.1038/srep01706. Sci Rep. 2013. PMID: 23609325 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical